Dry Beriberi Clinical Trial
— MABECOOfficial title:
Determination Study of Dry Beriberi in Patients Native to the Comoro Archipelago, in Mayotte (MABECO).
The purpose of this study is to assess the existence of a genetic factor, suspected to be involved, aside from likely food deficiency contribution, in occurrence of dry beriberi, in patients who experienced dry beriberi and in a case group composed of 3 people, free from beriberi, within the same household.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 15 Years and older |
Eligibility |
Inclusion Criteria: - patients - Native to the Comoro Archipelago (Grande Comore, Mayotte, Anjouan, Mohéli) - Fulfilling the clinical definition of the dry beriberi. - Both sexes. - Older than 15 years and 3 months (limit of the paediatrics). - Having signed and whose legal representatives signed the form of assent, having understood the information. - Benefiting from a social coverage regime. - Controls - Native to the Comoro Archipelago. - People living in the same household as the patient, sharing the same meals. - Both sexes. - Older than 15 years old and 3 months. - Free from beriberi. - With normal neurological examination. - Having signed and whose legal representatives signed the form of assent, having understood the information. - Benefiting from a social coverage regime. Exclusion Criteria: - Aged under 15-year-old and 3 months. - For the patients and the witnesses, the presence of pathologies known to increase needs in vitamin B1 (cancer, infectious diseases, fever, hyperthyroïdism, chronic alcoholism). |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
France | Central Hospital - MAYOTTE | Mamudzu |
Lead Sponsor | Collaborator |
---|---|
Groupe Hospitalier Sud Reunion |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mutations on one of the alleles of the promoter of the gene TKTL1 (transketolase-like gene) in the homozygous state in the patients and not in the controls (heterozygotes or not carrier of the mutation). | day 1 | No | |
Secondary | To evaluate food intakes in vitamin B1 and anti-thiamine factors (polyphenols). | day 1 | No | |
Secondary | To evaluate Thiamine biological status (blood thiamine, erythrocyte transketolase activity and the thiamine pyrophosphate effect) | day 1 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04977557 -
Thiamine in Patients With Clinically Suspected Dry Beriberi
|
N/A |